Bovine tuberculosis

(Barry) #1

 CAB International 2018. Bovine Tuberculosis
(eds M. Chambers, S. Gordon, F. Olea-Popelka, P. Barrow) 173


* Email: [email protected]

12.1 Introduction

Bovine tuberculosis (TB) is generally considered
a slowly progressive disease of extended dura-
tion (lasting years), and most cattle do not
exhibit readily apparent clinical signs of infec-
tion until late in the course of disease (Waters,
2015). Currently, agent-based strategies for the
detection of tuberculous cattle, such as detec-
tion of bacilli within bodily excretions, are gen-
erally unreliable for use as ante-mortem tests,
possibly due to the paucibacillary nature of the
disease resulting in a transient and low level of
bacterial shedding (Good and Duignan, 2011).
Thus, traditional clinical and microbiological
techniques are rarely used for the ante-mortem
diagnosis of bovine TB. Fortunately, Mycobacte-
rium bovis is highly immunogenic in cattle,
eliciting robust cell-mediated immune (CMI)
responses early in the course of disease, thereby
providing a useful surrogate of infection for a
disease in which ante-mortem detection of the
organism is difficult.
An immunological basis for the diagnosis
of TB was first realized shortly after Koch’s dis-
covery of tuberculin in 1890. With his studies,
Koch noted that injection of tuberculin into
Mycobacterium tuberculosis-infected humans
often resulted in systemic reactions including
hyperthermia. Using this information, veteri-
narians discovered that subcutaneous injection
of tuberculin also evoked a transient rise in body

temperature in tuberculous cattle and this reac-
tion could be of use as an immune-based diag-
nostic assay. The cumbersome subcutaneous
test was eventually replaced by a more sensitive
and practical intradermal tuberculin test. Along
with slaughter inspection followed by epidemio-
logic trace-back studies to determine herds of
origin for tuberculous carcasses, application of
the intradermal tuberculin test for removal of
test positive cattle has led to the complete eradi-
cation of bovine TB in Australia and near eradi-
cation of TB in Canada, most states within the
USA, New Zealand, and several European Union
countries (Cousins and Roberts, 2001; Good and
Duignan et al., 2011; Farnham et al., 2012;
Rivière et al., 2014; More et al., 2015). Despite
these advances, eradication and control efforts
are seriously hindered by the emergence of wild-
life reservoirs of M. bovis in multiple countries,
large-scale dairy calf and replacement heifer
rearing operations resulting in congregation
and widespread dispersal of single source-
infected animals, and increasing trade of cattle
(as a result of globalization of economies) from
regions with moderate bovine TB prevalence to
regions with very low prevalence (e.g. ~1 mil-
lion cattle shipped annually from Mexico to the
US). Thus, modern approaches requiring novel
and improved ante-mortem tests and testing
algorithms will be required to offset the emerg-
ing challenges in the control and eradication of
bovine TB.

12 Immunological Diagnosis


Ray Waters1,* and Martin Vordermeier^2

(^1) National Animal Disease Center, Agricultural Research Service, United States
Department of Agriculture, Ames, Iowa, USA;^2 Tuberculosis Research Group,
Animal and Plant Health Agency, Addlestone, UK

Free download pdf